<?xml version="1.0" encoding="UTF-8"?>
<p id="par0015">In 2012, the World Health Organization (WHO) launched the Battle against Respiratory Viruses (BRaVe) initiative 
 <xref rid="bib0015" ref-type="bibr">[3]</xref>, 
 <xref rid="bib0030" ref-type="bibr">[6]</xref> with the aim of tackling the burden of disease of RVIs globally. The BRaVe initiative identified priority research tracks and topic areas for future RVIs studies, and stressed the need to better define the epidemiology and burden of disease of specific RVIs across age spectrum and settings as a pre-requisite for implementing effective public health interventions 
 <xref rid="bib0015" ref-type="bibr">[3]</xref>. This is particularly important in low- and middle-income tropical countries, where RVIs place a massive burden on relatively fragile healthcare systems and have the highest socioeconomic impact.
</p>
